Opko Health, Inc. (OPK): Price and Financial Metrics

Opko Health, Inc. (OPK)

Today's Latest Price: $5.31 USD

0.05 (0.95%)

Updated Jan 27 8:34am

Add OPK to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

OPK Stock Summary

  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.45 for Opko Health Inc; that's greater than it is for just 22.15% of US stocks.
  • As for revenue growth, note that OPK's revenue has grown 29.53% over the past 12 months; that beats the revenue growth of 84.11% of US companies in our set.
  • In terms of volatility of its share price, OPK is more volatile than 75.32% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Opko Health Inc, a group of peers worth examining would be LIVN, MIND, BLIN, CPIX, and ITT.
  • Visit OPK's SEC page to see the company's official filings. To visit the company's web site, go to www.opko.com.

OPK Stock Price Chart Interactive Chart >

Price chart for OPK

OPK Price/Volume Stats

Current price $5.31 52-week high $6.47
Prev. close $5.26 52-week low $1.12
Day low $5.31 Volume 250,052
Day high $5.31 Avg. volume 6,800,415
50-day MA $4.39 Dividend yield N/A
200-day MA $3.73 Market Cap 3.56B

Opko Health, Inc. (OPK) Company Bio

Opko Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. The company was founded in 2005 and is based in Miami, Florida.

OPK Latest News Stream

Event/Time News Detail
Loading, please wait...

OPK Latest Social Stream

Loading social stream, please wait...

View Full OPK Social Stream

Latest OPK News From Around the Web

Below are the latest news stories about Opko Health Inc that investors may wish to consider to help them evaluate OPK as an investment opportunity.

OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia

GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion analysis for spinocerebellar ataxia (SCA), Friedreich ataxia, and other common forms of hereditary ataxias. With these additions, GeneDx has created a comprehensive and affordable offering that covers the vast majority of genes involved with pediatric-onset and adult-onset ataxias.

Yahoo | January 26, 2021

OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well as team and league staff for the 2020-2021 seasons for the National Basketball Association (NBA) and National Hockey League (NHL).

Yahoo | January 26, 2021

The OPKO Health (NASDAQ:OPK) Share Price Is Up 179% And Shareholders Are Boasting About It

When you buy shares in a company, there is always a risk that the price drops to zero. But when you pick a company that...

Yahoo | January 25, 2021

Opko Health expects to beat its guidance for PCR tests for Covid in 4Q

Opko Health (OPK) expects to beat its previously issued guidance for PCR tests for Covid-19 for 4Q and confirmed its revenue guidance, CFO Adam Logal said earlier at the JPMorgan Healthcare conference.Logal said Opko was profitable in 3Q and also guided for profitability in 4Q and expects a full year...

Seeking Alpha | January 14, 2021

OPKO Health's (OPK) BioReference Extends Digital Health Access

OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.

Yahoo | January 14, 2021

Read More 'OPK' Stories Here

OPK Price Returns

1-mo 35.46%
3-mo 26.43%
6-mo 3.11%
1-year 229.81%
3-year 8.81%
5-year -33.96%
YTD 34.43%
2020 168.71%
2019 -51.16%
2018 -38.57%
2017 -47.31%
2016 -7.46%

Continue Researching OPK

Want to see what other sources are saying about Opko Health Inc's financials and stock price? Try the links below:

Opko Health Inc (OPK) Stock Price | Nasdaq
Opko Health Inc (OPK) Stock Quote, History and News - Yahoo Finance
Opko Health Inc (OPK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0366 seconds.